Rocket Pharmaceuticals (RCKT)
(Delayed Data from NSDQ)
$23.47 USD
+0.70 (3.07%)
Updated May 3, 2024 04:00 PM ET
After-Market: $23.45 -0.02 (-0.09%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth B Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/02/2024
Time: -- |
3/2024 | $-0.69 | -6.99% |
Earnings Summary
For their last quarter, Rocket Pharmaceuticals (RCKT) reported earnings of -$0.64 per share, beating the Zacks Consensus Estimate of $-0.80 per share. This reflects a positive earnings surprise of 20.00%. Look out for RCKT's next earnings release expected on May 02, 2024. For the next earning release, we expect the company to report earnings of -$0.69 per share, reflecting a year-over-year increase of 5.48%.
Earnings History
Price & Consensus
Zacks News for RCKT
EMA Accepts Rocket (RCKT) Gene Therapy Filing for Fanconi Anemia
RCKT: What are Zacks experts saying now?
Zacks Private Portfolio Services